Literature DB >> 12948744

Neonatal liver failure and Leigh syndrome possibly due to CoQ-responsive OXPHOS deficiency.

E Leshinsky-Silver1, A Levine, A Nissenkorn, V Barash, M Perach, E Buzhaker, M Shahmurov, S Polak-Charcon, D Lev, T Lerman-Sagie.   

Abstract

CoQ transfers electrons from complexes I and II of the mitochondrial respiratory chain to complex III. There are very few reports on human CoQ deficiency. The clinical presentation is usually characterized by: epilepsy, muscle weakness, ataxia, cerebellar atrophy, migraine, myogloblinuria and developmental delay. We describe a patient who presented with neonatal liver and pancreatic insufficiency, tyrosinemia and hyperammonemia and later developed sensorineural hearing loss and Leigh syndrome. Liver biopsy revealed markedly reduced complex I+III and II+III. Addition of CoQ to the liver homogenate restored the activities, suggesting CoQ depletion. Histological staining showed prominent bridging; septal fibrosis and widening of portal spaces with prominent mixed inflammatory infiltrate, associated with interface hepatitis, bile duct proliferation with numerous bile plugs. Electron microscopy revealed a large number of mitochondria, which were altered in shape and size, widened and disordered intercristal spaces. This may be the first case of Leigh syndrome with liver and pancreas insufficiency, possibly caused by CoQ responsive oxphos deficiency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948744     DOI: 10.1016/s1096-7192(03)00097-0

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  14 in total

1.  Clinical presentations of coenzyme q10 deficiency syndrome.

Authors:  Catarina M Quinzii; Valentina Emmanuele; Michio Hirano
Journal:  Mol Syndromol       Date:  2014-07

Review 2.  Coenzyme Q and mitochondrial disease.

Authors:  Catarina M Quinzii; Michio Hirano
Journal:  Dev Disabil Res Rev       Date:  2010

3.  Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.

Authors:  Konstantina Fragaki; Samira Ait-El-Mkadem; Annabelle Chaussenot; Catherine Gire; Raymond Mengual; Laurent Bonesso; Marie Bénéteau; Jean-Ehrland Ricci; Valérie Desquiret-Dumas; Vincent Procaccio; Agnès Rötig; Véronique Paquis-Flucklinger
Journal:  Eur J Hum Genet       Date:  2012-09-19       Impact factor: 4.246

Review 4.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

Review 5.  Coenzyme Q10 deficiencies in neuromuscular diseases.

Authors:  Rafael Artuch; Leonardo Salviati; Sandra Jackson; Michio Hirano; Plácido Navas
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 6.  Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10).

Authors:  Rita Horvath
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

Review 7.  Heterogeneity of coenzyme Q10 deficiency: patient study and literature review.

Authors:  Valentina Emmanuele; Luis C López; Luis López; Andres Berardo; Ali Naini; Saba Tadesse; Bing Wen; Erin D'Agostino; Martha Solomon; Salvatore DiMauro; Catarina Quinzii; Michio Hirano
Journal:  Arch Neurol       Date:  2012-08

Review 8.  Primary and secondary CoQ(10) deficiencies in humans.

Authors:  Catarina M Quinzii; Michio Hirano
Journal:  Biofactors       Date:  2011-10-11       Impact factor: 6.113

Review 9.  Primary coenzyme Q10 (CoQ 10) deficiencies and related nephropathies.

Authors:  Fatih Ozaltin
Journal:  Pediatr Nephrol       Date:  2013-06-05       Impact factor: 3.714

Review 10.  New insights into mitochondrial structure during cell death.

Authors:  Guy Perkins; Ella Bossy-Wetzel; Mark H Ellisman
Journal:  Exp Neurol       Date:  2009-05-21       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.